Hepatic Cell News Volume 7.44 | Nov 24 2023

    0
    10







    2023-11-24 | HCN 7.44


    Hepatic Cell News by STEMCELL Technologies
    Vol. 7.44 – 24 November, 2023
    TOP STORY

    Intestinal Atp8b1 Dysfunction Causes Hepatic Choline Deficiency and Steatohepatitis

    Atp8b1 regulated hepatic choline levels through intestinal lysoPC absorption, encouraging the evaluation of choline supplementation therapy for steatohepatitis caused by ATP8B1 dysfunction.
    [Nature Communications]

    Full Article
    Scientific resources to support your organoids research. Learn More!
    PUBLICATIONSRanked by the impact factor of the journal

    Targeting Ferroptosis by Poly(acrylic) Acid Coated Mn3O4 Nanoparticles Alleviates Acute Liver Injury

    Researchers reported a simple and one-pot synthesis of ultrasmall poly(acrylic) acid-coated Mn3O4 nanoparticles which performed multiple antioxidant enzyme-mimicking activities and could scavenge broad-spectrum reactive oxygen species.
    [Nature Communications]

    Full Article

    A Multicellular Liver Organoid Model for Investigating Hepatitis C Virus Infection and Non-Alcoholic Fatty Liver Disease Progression

    Investigators presented a novel, multicellular liver organoid model using a co-culture system of macrophages and liver organoids differentiated from the same human pluripotent stem cells.
    [Hepatology]

    AbstractGraphical Abstract

    Liver Cancer Stem Cell Dissemination and Metastasis: Uncovering the Role of NRCAM in Hepatocellular Carcinoma

    Scientists revealed the contributions of NRCAM to liver cancer stem cell function and HCC metastasis, and further explored its mechanism in detail.
    [Journal Of Experimental & Clinical Cancer Research]

    Full Article

    SIRT1 Regulates Hepatocyte Programmed Cell Death via GSDME – IL18 Axis in Human and Mouse Liver Transplantation

    Researchers undertook translational studies in human and mouse orthotopic liver transplantation to interrogate the significance of hepatocyte-specific Sirtuin 1 (SIRT1) in cold-stored donor livers and liver grafts after reperfusion.
    [Cell Death & Disease]

    Full Article

    Pretreatment of UC-MSCs with IFN-α2 Improves Treatment of Liver Fibrosis by Recruiting Neutrophils

    Researchers explored therapeutic umbilical cord (UC)-MSC phenotypes for improving liver fibrosis.
    [Journal Of Translational Medicine]

    Full Article

    USP35 Promotes HCC Development by Stabilizing ABHD17C and Activating the PI3K/AKT Signaling Pathway

    Scientists identified multiple ubiquitin-specific proteases (USPs) that could stabilize ABHD17C by inhibiting the ubiquitin-proteasome-mediated degradation.
    [Cell Death Discovery]

    Full Article

    EMT-Related Gene Risk Model Establishment for Prognosis and Drug Treatment Efficiency Prediction in Hepatocellular Carcinoma

    Investigators evaluated the prognosis and pharmacological therapy sensitivity of epithelial mesenchymal transition-related genes that obtained from the EMTome database in HCC using bioinformatical method.
    [Scientific Reports]

    Full Article

    3D Multi-Cell-Type Liver Organoids: A New Model of Non-Alcoholic Fatty Liver Disease for Drug Safety Assessments

    Researchers generated three-dimensional multi-cell-type liver organoids from HepaRG cells, primary human macrophages, and hepatic-stellate-cell-derived LX-2 cells.
    [Toxicology In Vitro]

    Full Article
    Scientific resources to support your organoids research. Learn More!
    REVIEWS

    Tracking of Stem Cells in Chronic Liver Diseases: Current Trends and Developments

    The authors aim to comprehensively evaluate the current state of methods for tracking stem cells, highlighting their strengths and weaknesses, and providing insights into their future potential.
    [Stem Cell Reviews And Reports]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-Week Phase II Study of Advanced (F3) MASH Liver Disease

    Hepion Pharmaceuticals, Inc. announced additional efficacy data for rencofilstat, its lead drug candidate for the treatment of metabolic dysfunction-associated steatohepatitis, fibrotic diseases, HCC, and other chronic diseases.
    [Hepion Pharmaceuticals, Inc.]

    Press Release
    FEATURED EVENT

    9th International Conference on Mechanics of Biomaterials and Tissues

    December 16 – 20, 2023
    Waikoloa Beach, Hawaii, United States

    > See All Events

    JOB OPPORTUNITIES

    Senior Scientist- Hepatitis E Virus

    Animal & Plant Health Agency – Addlestone, England, United Kingdom

    Research Assistant – Epigenetics

    Babraham Institute – Cambridge, England, United Kingdom

    PhD Student – Cancer Science

    University of Oxford – Oxford, England, United Kingdom

    Postdoctoral Researcher – Cancer Bioinformatics and Immunotherapies

    Armenian Bioinformatics Institute – Yerevan, Armenia

    Postdoctoral Scientist – Cancer Research Cluster

    Cedars-Sinai – Los Angeles, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2